Literature DB >> 24551688

Myxoid leiomyoma of cervix.

Hemlata T Kamra1, Sunita S Dantkale2, Khusboo Birla3, Pankaj W Sakinlawar3, Rahul R Narkhede3.   

Abstract

Leiomyoma, a benign smooth muscle tumour of uterus, is the most common pelvic tumour which occurs in women of reproductive age group. Uterine leiomyomas are frequently seen in women who are older than 30 years of age and they are very rarely seen in women who are below the age of 18 years. They tend to regress after menopause. Incidence is 4% in women who are below 30 years of age. However , lifetime risk of fibroids in women who are over the age of 45 years is more than 60%, with an incidence which is higher in blacks than in whites Cervical leiomyomas constitute 1-2% of the total leiomyoma cases and they rarely occur. There are three types of cervical leiomyomas, namely; interstitial, supravaginal, and polypoidal. Supravaginal leiomyoma is the commonest type. Large cervical fibroids present with abdominal masses, incarcerated procidentia, uterine inversion, cervical malignancy, etc. The prevalence of fibroids during pregnancy, irrespective of site, has been reported to be 1-4%. Degeneration in leiomyomas have been described in 65% of the cases. Myxoid leiomyoma is characterized by absence of mito tic activity and the presence of myogenic phenotype. The higher end of prevalence for a myxoid degeneration has been reported in upto 50% of all degenerations in uterus, but myxoid leiomyoma has been rarely described in cervix. Cause of a myxoid change in pregnancy is unknown.

Entities:  

Keywords:  Cervix; Leiomyoma; Myxoid; Pregnancy

Year:  2013        PMID: 24551688      PMCID: PMC3919339          DOI: 10.7860/JCDR/2013/6171.3805

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  4 in total

1.  MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas.

Authors:  Netta Mäkinen; Miika Mehine; Jaana Tolvanen; Eevi Kaasinen; Yilong Li; Heli J Lehtonen; Massimiliano Gentile; Jian Yan; Martin Enge; Minna Taipale; Mervi Aavikko; Riku Katainen; Elina Virolainen; Tom Böhling; Taru A Koski; Virpi Launonen; Jari Sjöberg; Jussi Taipale; Pia Vahteristo; Lauri A Aaltonen
Journal:  Science       Date:  2011-08-25       Impact factor: 47.728

Review 2.  Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds.

Authors:  H Ueda; K Togashi; I Konishi; M L Kataoka; T Koyama; T Fujiwara; H Kobayashi; S Fujii; J Konishi
Journal:  Radiographics       Date:  1999-10       Impact factor: 5.333

3.  Smooth muscle tumors of the vulva.

Authors:  F A Tavassoli; H J Norris
Journal:  Obstet Gynecol       Date:  1979-02       Impact factor: 7.661

4.  Transforming growth interacting factor expression in leiomyoma compared with myometrium.

Authors:  Jason Yen-Ping Ho; Weng Chi Man; Yan Wen; Mary Lake Polan; Esther Shih-Chu Ho; Bertha Chen
Journal:  Fertil Steril       Date:  2009-06-13       Impact factor: 7.329

  4 in total
  3 in total

1.  Novel management of a giant cervical myoma in a premenopausal patient.

Authors:  Jolene Wong; Grace Hwei Ching Tan; Ravichandran Nadarajah; Melissa Teo
Journal:  BMJ Case Rep       Date:  2017-10-09

Review 2.  Current Treatment Options for Cervical Leiomyomas: A Systematic Review of Literature.

Authors:  Federico Ferrari; Sara Forte; Gaetano Valenti; Laura Ardighieri; Fabio Barra; Valentina Esposito; Enrico Sartori; Franco Odicino
Journal:  Medicina (Kaunas)       Date:  2021-01-21       Impact factor: 2.430

3.  Pelvic Myxoid Leiomyoma Mass between Vagina and Rectum.

Authors:  Omar AlShalabi; Fadi Obaied Alahmar; Hazem Aljasem; Bayan Alsaid; Abdulghani AlShalabi
Journal:  Case Rep Surg       Date:  2016-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.